Evidence map›Paper›PMID 35129225›Full record

ArticleAddiction (Abingdon, England)2022

Infrequent detection of unintentional fentanyl use via urinalysis among people who regularly inject opioids in Sydney and Melbourne, Australia.

Tina Lam, Monica J Barratt, Mark Bartlett, Julie Latimer, Marianne Jauncey, Sarah Hiley, Nico Clark, Dimitri Gerostamoulos, Linda Glowacki, Claude Roux and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Addiction (Abingdon, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. A Perspective on Psychedelics as Treatments for Addictions.Journal of studies on alcohol and drugs · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Tina LamMonash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.ORCID 0000-0002-4902-7293
Monica J BarrattSocial and Global Studies Centre and Digital Ethnography Research Centre, RMIT University, Melbourne, VIC, Australia.ORCID 0000-0002-1015-9379
Mark BartlettUniting Medically Supervised Injecting Centre, Sydney, NSW, Australia.
Julie LatimerUniting Medically Supervised Injecting Centre, Sydney, NSW, Australia.
Marianne JaunceyUniting Medically Supervised Injecting Centre, Sydney, NSW, Australia.
Sarah HileyMedically Supervised Injecting Room, North Richmond Community Health, Melbourne, VIC, Australia.
Nico ClarkMedically Supervised Injecting Room, North Richmond Community Health, Melbourne, VIC, Australia.
Dimitri GerostamoulosVictorian Institute of Forensic Medicine, Melbourne, VIC, Australia.
Linda GlowackiVictorian Institute of Forensic Medicine, Melbourne, VIC, Australia.
Claude RouxCentre for Forensic Science, University of Technology Sydney, NSW, Australia.
Marie MorelatoCentre for Forensic Science, University of Technology Sydney, NSW, Australia.
Suzanne NielsenMonash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.ORCID 0000-0001-5341-1055
Australian Broadcasting Corporation (Australia) · AUMelbourne Health · AUUniversity of Technology Sydney · AUUNSW Sydney · AUVictorian Institute of Forensic Medicine · AUEastern Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimThe current phase of the North American 'opioid crisis' is characterised by illicit fentanyl use; however, the presence of illicit fentanyl in Australia is unknown. This study aimed to monitor unintentional fentanyl consumption in Australia.

designRapid urine drug screens (UDS) paired with surveys conducted within supervised injecting facilities (SIFs) and confirmatory laboratory testing.

settingSydney and Melbourne, Australia.

participantsClients who used heroin within the past 2 days (n = 911 tests, 2017-2021). Participants were demographically similar to the overall client base (median age 43, 72% male). MEASUREMENTS: UDS were conducted using BTNX Rapid Response fentanyl urine strip tests with cross-reactivity to numerous fentanyl analogues. Positive urine samples were analysed using liquid chromatography coupled with tandem mass spectrometry. Surveys covered past 3 day drug use and lifetime report of fentanyl in heroin.

findingsTwo percent of participants reported intentional use of fentanyl, mostly through fentanyl patches. Of the 911 rapid UDS conducted, 17 (1.9%) yielded positive results. Eight of these (all from Melbourne) were not explained by survey-reported fentanyl use in the past 3 days. Of these 8 unexplained positives, confirmatory laboratory analysis was conducted on 6, with 4 deemed to be false positives, and 2 confirmed for the presence of fentanyl. This represents the first confirmation of unintended use of fentanyl type substances in this population.

conclusionThere is limited evidence of unintentional fentanyl use among people in Sydney and Melbourne, Australia who regularly inject heroin, suggesting that, currently, there is very little illicit fentanyl in Australian drug markets accessed by supervised injecting facilities attendees. This study demonstrates the feasibility of quick onsite testing to cost-effectively screen large samples for fentanyl; however, the high false positive rate emphasises the need for confirmation of positive tests through advanced analytical techniques.

Indexed as

Drug OverdoseOpioid-Related DisordersAdultAnalgesics, OpioidAustraliaFemaleFentanylHeroinHumansMaleUrinalysisAnalgesics, OpioidFentanylHeroinFentanylheroinimmunoassayopioidsentinel surveillanceSupervised Injecting Centers

Identifiers

PMID35129225
PMCPMC9544654
OpenAlexW4210804585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.